Shuai Li
- Cancer Research top 5%
- Breast Cancer Treatment Studies 8
- Cancer-related molecular mechanisms research 6
-
- Advanced biosensing and bioanalysis techniques 6
- CRISPR and Genetic Engineering 5
- Epigenetics and DNA Methylation 5
- RNA and protein synthesis mechanisms 4
- Biophysics top 10%
-
- HER2/EGFR in Cancer Research 5
-
- Breast Lesions and Carcinomas 8
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesChile
In The Last Decade
Shuai Li
61 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 373
- Molecular Biology 546
- Biophysics 43
- Structural Biology 10
- Oncology 170
Countries citing papers authored by Shuai Li
This map shows the geographic impact of Shuai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Li more than expected).
Fields of papers citing papers by Shuai Li
This network shows the impact of papers produced by Shuai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Li. The network helps show where Shuai Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuai Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 7 | |
| 7 | Postoperative Short-term Outcomes Between Sublobar Resection and Lobectomy in Patients with Lung Adenocarcinoma | 2020 | 0 |
| 8 | Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study | 2020 | 2 |
| 9 | Long Noncoding RNA SNHG6 Functions as an Oncogene in Non-Small Cell Lung Cancer via Modulating ETS1 Signaling | 2020 | 2 |
| 10 | Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer | 2020 | 4 |
| 11 | 2020 | 7 | |
| 12 | 2019 | 6 | |
| 13 | Knockdown of cyclooxygenase-2 leads to growth inhibition and cell cycle arrest in hepatocellular carcinoma cells | 2019 | 1 |
| 14 | 2019 | 1 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 6 | |
| 17 | 2016 | 37 | |
| 18 | 2012 | 2 | |
| 19 | 2012 | 7 | |
| 20 | Study on Effect of Magnetic Treatment on Sludge Dewatering Ability | 2007 | 3 |
About Shuai Li
Shuai Li is a scholar working on Cancer Research, Oncology and Structural Biology, having authored 66 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Cancer-related molecular mechanisms research (6 papers), CRISPR and Genetic Engineering (5 papers), HER2/EGFR in Cancer Research (5 papers), Epigenetics and DNA Methylation (5 papers) and RNA and protein synthesis mechanisms (4 papers). The work is most often cited by research in Cancer Research (373 citations), Molecular Biology (546 citations) and Biophysics (43 citations). Shuai Li has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Fangfang Liu, Jie Zhu, Hanjiang Fu, Ruiyun Xing, Yulan Wang, Xiaofei Zheng, Xinmin Zhang, Lixin Wei, Zhixian Sun and Yi Tie. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.